Author:
Krylova T. A.,Musorina A. S.,Koltsova A. M.,Zenin V. V.,Turilova V. I.,Yakovleva T. K.,Poljanskaya G. G.
Reference47 articles.
1. Ali, H., Al-Yatama, M.K., Abu-Farha, M., Behbehani, K., and Al Madhoun, A., Multi-lineage differentiation of human umbilical cord Wharton’s jelly mesenchymal stromal cells mediates changes in the expression profile of stemness markers, PLoS One, 2015, vol. 10. e0122465. doi 10.1371/journal.pone.0122465
2. An International System for Human Cytogenetic Nomenclature, Shaffer, I.G., Slovak, M.L., and Campbell, L.J., Eds., Basel: Karger, 2009.
3. Antonucci, I., Stuppia, L., Kaneko, Y., Yu, S., Tajiri, N., Bae, E.C., Chheda, S.H., Weinbren, N.L., and Borlongan, C.V., Amniotic fluid as rich source of mesenchymal stromal cells for transplantation therapy, Cell Transplant., 2011, vol. 20, pp. 789–795.
4. Araújo, A.B., Salton, G.D., Furlan, J.M., Schneider, N., Angeli, M.H., Laureano, Á.M., Silla, L., Passos, E.P., and Paz, A.H., Comparison of human mesenchymal stromal cells from four neonatal tissues: amniotic membrane, chorionic membrane, placental decidua and umbilical cord, Cytotherapy, 2017, vol. 19, pp. 577–585.
5. Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., Büscher, D., Fibbe, W., Foussat, A., Kwa, M., Lantz, O., Maciulaitis, R., Palomäki, T., Schneider, C.K., Sensebé, L., Tachdjian, G., Tarte, K., Tosca, L., and Salmikangas, P., Risk of tumorigenicity in mesenchymal stromal cell-based therapies—bridging scientific observations and regulatory viewpoints, Cytotherapy, 2013, vol. 15, pp. 753–759.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献